<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ISOSORBIDE MONONITRATE</span><br/>(eye-soe-sor'bide)<br/><span class="topboxtradename">Ismo, </span><span class="topboxtradename">Imdur, </span><span class="topboxtradename">Monoket<br/></span><b>Classifications:</b> <span class="classification">cardiovascular agent</span>; <span class="classification">nitrate vasodilator</span><br/><b>Prototype: </b>Nitroglycerin<br/><b>Pregnancy Category: </b>C (category B for sustained release form)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 20 mg tablets; 30 mg, 60 mg, 120 mg sustained release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Isosorbide mononitrate is a long-acting metabolite of the coronary vasodilator isosorbide dinitrate. It decreases preload
         as measured by pulmonary capillary wedge pressure (PCWP), and left ventricular end volume and diastolic pressure (LVEDV),
         with a consequent reduction in myocardial oxygen consumption.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It is equally or more effective than isosorbide dinitrate in the treatment of chronic, stable angina. It is a potent vasodilator
         with antianginal and antiischemic effects.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Prevention of angina. Not indicated for acute attacks.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to nitrates; severe anemia; closed-angle glaucoma, postural hypotension, head trauma, cerebral hemorrhage
         (increases intracranial pressure). Safe use during pregnancy [(category C) and (category B) for sustained form] or lactation
         is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Older adults, hypotension.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Prevention of Angina</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> Regular release (ISMO, Monoket) 20 mg b.i.d. 7 h apart; Sustained release (Imdur) 3060 mg every morning, may increase
               up to 120 mg once daily after several days if needed (max: dose 240 mg)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give first dose in morning on arising and second dose 7 h later with twice daily dosing regimen. Give in morning on arising
            with once daily dosing.
         </li>
<li>Store sustained release tablets in a tight container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache, agitation, anxiety, confusion, loss of coordination, hypoesthesia, hypokinesia, insomnia or somnolence, nervousness,
      migraine headache, paresthesia, vertigo, ptosis, tremor. <span class="typehead">CV:</span> Aggravation of angina, abnormal heart sounds, murmurs, <span class="speceff-life">MI</span>, transient hypotension, palpitations. <span class="typehead">Hematologic:</span> Hypochromic anemia, purpura, thrombocytopenia, methemoglobinemia (high doses). <span class="typehead">GI:</span> Nausea, vomiting, dry mouth, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, tenesmus, gastric ulcer, hemorrhoids,
      gastritis, glossitis. <span class="typehead">Metabolic:</span> Hyperuricemia, hypokalemia. <span class="typehead">GU:</span> Renal calculus, UTI, atrophic vaginitis, dysuria, polyuria, urinary frequency, decreased libido, impotence. <span class="typehead">Respiratory:</span> Bronchitis, pneumonia, upper respiratory tract infection, nasal congestion, bronchospasm, coughing, dyspnea, rales, rhinitis. <span class="typehead">Skin:</span> Rash, pruritus, hot flashes, acne, abnormal texture. <span class="typehead">Special Senses:</span> Diplopia, blurred vision, photophobia, conjunctivitis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> may cause severe hypotension and cardiovascular collapse. <b>Aspirin</b> may increase nitrate serum levels. <span class="classification">calcium channel blockers</span> may cause orthostatic hypotension. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Completely and rapidly absorbed from GI tract; 93% reaches systemic circulation. <span class="typehead">Onset:</span> 1 h. <span class="typehead">Peak:</span> Regular release 3060 min; sustained release 34 h. <span class="typehead">Duration:</span> Regular release 512 h; sustained release 12 h. <span class="typehead">Metabolism:</span> Metabolized in liver by denitration and conjugation to inactive metabolites. <span class="typehead">Elimination:</span> Excreted primarily by kidneys. <span class="typehead">Half-Life:</span> 45 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor cardiac status, frequency and severity of angina, and BP.</li>
<li>Assess for and report possible S&amp;S of toxicity, including orthostatic hypotension, syncope, dizziness, palpitations, light-headedness,
            severe headache, blurred vision, and difficulty breathing.
         </li>
<li>Lab tests: Monitor serum electrolytes periodically.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not crush or chew sustained release tablets. May break tablets in two and take with adequate fluid (48 oz).</li>
<li>Do not withdraw drug abruptly; doing so may precipitate acute angina.</li>
<li>Maintain correct dosing interval with twice daily dosing.</li>
<li> 							Note: Geriatric patients are more susceptible to the possibility of developing postural hypotension. 						</li>
<li>Avoid alcohol ingestion and aspirin unless specifically permitted by physician.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>